The shifted balance of arginine metabolites in acute myocardial infarction patients and its clinical relevance

[1]  T. Zeller,et al.  Analysis of L-arginine:glycine amidinotransferase-, creatine- and homoarginine-dependent gene regulation in the murine heart , 2020, Scientific Reports.

[2]  G. Heusch.  Coronary microvascular obstruction: the new frontier in cardioprotection , 2019, Basic Research in Cardiology.

[3]  S. Blankenberg,et al.  Effect of ranolazine on plasma arginine derivatives and urinary isoprostane 8-iso-PGF2α in patients with myocardial infarction in the randomized RIMINI-Trial , 2019, Scientific Reports.

[4]  G. Heusch,et al.  Cardioprotection Beyond Infarct Size Reduction. , 2019, Circulation research.

[5]  F. Crea,et al.  The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. , 2018, Cardiovascular research.

[6]  M. Gladwin,et al.  Nitrite and nitrate chemical biology and signalling , 2018, British journal of pharmacology.

[7]  C. Östenson,et al.  Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I. , 2018, Journal of the American College of Cardiology.

[8]  R. Caldwell,et al.  Arginase: A Multifaceted Enzyme Important in Health and Disease. , 2018, Physiological reviews.

[9]  A. Braun,et al.  The vascular endothelium: A regulator of arterial tone and interface for the immune system , 2017, Critical reviews in clinical laboratory sciences.

[10]  D. Andreini,et al.  Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction: A Study of the Collaborative Registry on CMR in STEMI. , 2017, JACC. Cardiovascular imaging.

[11]  V. Fuster,et al.  Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition After Myocardial Infarction , 2017, Circulation research.

[12]  L. Liang,et al.  Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study , 2017, The Journal of clinical endocrinology and metabolism.

[13]  S. Morris.  Arginine Metabolism Revisited. , 2016, The Journal of nutrition.

[14]  R. Schulz,et al.  Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart , 2015, Front. Physiol..

[15]  T. Nabika,et al.  Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study. , 2015, Atherosclerosis.

[16]  F. Van de Werf,et al.  Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion , 2015, Basic Research in Cardiology.

[17]  M. Gladwin,et al.  Pitfalls in measuring NO bioavailability using NOx. , 2015, Nitric oxide : biology and chemistry.

[18]  A. Popolo,et al.  l-Arginine and its metabolites in kidney and cardiovascular disease , 2014, Amino Acids.

[19]  C. Pierrakos,et al.  Effects of L-NAME on coronary blood flow, infarct size and the extent of the no-reflow phenomenon. , 2013, International journal of cardiology.

[20]  M. Gladwin,et al.  Circulating Blood Endothelial Nitric Oxide Synthase Contributes to the Regulation of Systemic Blood Pressure and Nitrite Homeostasis , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[21]  K. Channon,et al.  Myocardial protection by co-administration of L-arginine and tetrahydrobiopterin during ischemia and reperfusion. , 2013, International journal of cardiology.

[22]  D. Wolters,et al.  Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease. , 2012, Blood.

[23]  H. Westerblad,et al.  Local Arginase Inhibition during Early Reperfusion Mediates Cardioprotection via Increased Nitric Oxide Production , 2012, PloS one.

[24]  Yuejin Yang,et al.  PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow. , 2012, Microvascular research.

[25]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[26]  P. Marsden,et al.  Nitric oxide signaling in hypoxia , 2012, Journal of Molecular Medicine.

[27]  R. Vasan,et al.  Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort. , 2011, The Journal of nutrition.

[28]  M. Kanbay,et al.  Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. , 2011, Atherosclerosis.

[29]  W. März,et al.  Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. , 2011, Atherosclerosis.

[30]  H. Arnesen,et al.  The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training. , 2011, Journal of cardiac failure.

[31]  Stanley L Hazen,et al.  Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks: Potential Mechanisms Beyond Nitric Oxide Synthase Inhibition , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[32]  S. Hazen,et al.  Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. , 2009, Journal of the American College of Cardiology.

[33]  S. Hazen,et al.  Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction , 2007, Circulation.

[34]  L. Ignarro,et al.  The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. , 2007, Pharmacology & therapeutics.

[35]  D. Pitocco,et al.  Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the Griess assay. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[36]  Thomas Lauer,et al.  Red blood cells express a functional endothelial nitric oxide synthase. , 2006, Blood.

[37]  D. Kass,et al.  L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. , 2006, JAMA.

[38]  Bryan Langholz,et al.  Case–Cohort Study , 2005 .

[39]  P. Pieniążek,et al.  Detection of microvascular injury by evaluating epicardial blood flow in early reperfusion following primary angioplasty. , 2004, International journal of cardiology.

[40]  N. Alp,et al.  Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[41]  R. Kloner,et al.  Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. , 2002, American journal of physiology. Heart and circulatory physiology.

[42]  R. Kloner,et al.  Rapid expansion of anatomical no-reflow during reperfusion in the rabbit , 2002 .

[43]  T. Rassaf,et al.  Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Rosenkranz,et al.  Central role for ornithine decarboxylase in β-adrenoceptor mediated hypertrophy , 2000 .

[45]  P. Tsao,et al.  Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.

[46]  Jan Fawcett,et al.  Which Comes First , 1996 .

[47]  Yunchao Su,et al.  Acute hypoxia increases intracellular L‐arginine content in cultured porcine pulmonary artery endothelial cells , 1996, Journal of cellular physiology.

[48]  S. Kostyk,et al.  Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. , 1994, The American journal of physiology.

[49]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[50]  M. Fishbein,et al.  The Relationship of Vascular Injury and Myocardial Hemorrhage to Necrosis After Reperfusion , 1980, Circulation.

[51]  E. Braunwald,et al.  Ultrastructural Evidence of Microvascular Damage and Myocardial Cell Injury After Coronary Artery Occlusion: Which Comes First? , 1980, Circulation.

[52]  Fukunaga Mai,et al.  日本人におけるセリアック病有病率の検討:Shimane CoHRE Study , 2018 .

[53]  A. Rodriguez-Mateos,et al.  identification and visualization of erythrocytic eNOS activity in health and disease , 2016 .

[54]  Christian Jung,et al.  Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. , 2010, Cardiovascular research.

[55]  D. Giustarini,et al.  Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. , 2008, Methods in enzymology.

[56]  F. Kajiya,et al.  Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. , 2007, Clinical hemorheology and microcirculation.

[57]  E. Block,et al.  Role of membrane potential in hypoxic inhibition of L-arginine uptake by lung endothelial cells. , 1997, The American journal of physiology.